Resolution Therapeutics Names Lucy Singah CFO, Daniel Kennedy CBO
10 Sep 2025 //
PR NEWSWIRE
Resolution Tx Doses First Patient in RTX001 Ph I/II Study
04 Sep 2025 //
PHARMAWEB
Resolution Therapeutics Doses First Patient in Phase I/II RTX001
03 Sep 2025 //
PR NEWSWIRE
Resolution Therapeutics to Host Virtual R&D Webinar
27 Aug 2025 //
PR NEWSWIRE
Resolution Announces Fibrosis Presentation at Keystone Symposia
10 Dec 2024 //
PR NEWSWIRE
Resolution Expands RTX001 Phase 1/2 EMERALD Study into Spain
19 Nov 2024 //
PR NEWSWIRE
Resolution Therapeutics Presents Data for RTX001 in Liver Disease
11 Nov 2024 //
PR NEWSWIRE
Resolution Therapeutics Raises £63.5M In Series B, Appoints Chair
03 Oct 2024 //
PR NEWSWIRE